Cytek Biosciences(CTKB.US)

Last Updated 19:00:00 ET
longbridge loading

Cytek Biosciences Faces Rising Risk From U.S.–China Trade Tensions and Tariff Pressures

Tip Ranks·
US
CTKB
+0.56%
US
PBE
+0.11%
US
BBH
+0.68%
Tip Ranks·
US
CTKB
+0.56%
US
PBE
+0.11%
US
BBH
+0.68%

Cytek Biosciences Balances Growth Momentum With Cost Pressures

Tip Ranks·
US
CTKB
+0.56%
US
XBI
-0.69%
US
FBT
+0.54%
Tip Ranks·
US
CTKB
+0.56%
US
XBI
-0.69%
US
FBT
+0.54%

Cytek Biosciences | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 44.14 M

Earnings Watch·
US
CTKB
+0.56%
Earnings Watch·
US
CTKB
+0.56%

Cytek reaffirms $205M-$212M 2026 revenue outlook as US growth rebounds

MSN·
US
CTKB
+0.56%
US
BBH
+0.68%
US
SBIO
-1.24%
MSN·
US
CTKB
+0.56%
US
BBH
+0.68%
US
SBIO
-1.24%

Cytek Biosciences | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 44.14 M

Earnings Watch·
US
CTKB
+0.56%
Earnings Watch·
US
CTKB
+0.56%

Lantronix shares are trading lower after the company reported worse-than-expected Q3 sales results.

benzinga_article·
US
LTRX
+0.79%
benzinga_article·
US
LTRX
+0.79%

12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga_article·
US
GMED
+1.27%
US
CAI
-0.93%
US
CTKB
+0.56%
benzinga_article·
US
GMED
+1.27%
US
CAI
-0.93%
US
CTKB
+0.56%

Cyted Health's US Laboratory Achieves College of American Pathologists Accreditation

Unusual Whales·
US
HLTHQ
0.00%
US
CTKB
+0.56%
US
IBB
+0.10%
Unusual Whales·
US
HLTHQ
0.00%
US
CTKB
+0.56%
US
IBB
+0.10%
© 2026 Longbridge｜Disclaimer